-+ 0.00%
-+ 0.00%
-+ 0.00%

*Kalaris Therapeutics: Preliminary Data From Ongoing Phase 1b/2 Study of TH103 in nAMD Now Expected 2H 2027 >KLRS

Dow Jones·11/10/2026 12:33:33